VIRX: Nilai perusahaan marang bathi resik viracta.com

Viracta Therapeutics, Inc. - logo grafis emiten VIRX

The Viracta Therapeutics (VIRX) price chart demonstrates the -0.10 metric, which correlates with the biotech firm's activities in developing therapies for Epstein-Barr virus-driven lymphomas. The business relies on expansion within the targeted drug segment, aiming to capture a significant share of the oncology market. Professional management is focused on bringing unique medications to market through the precise administration of clinical trial stages.

Koefisien rega marang bathi: Viracta (VIRX) kanggo 04.07.2022 - 08.02.2025

Rincian metrik komprehensif lan analitis Viracta Therapeutics Inc. (VIRX)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega Viracta Therapeutics, Inc.|VIRX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Viracta Therapeutics Inc.|VIRX - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham Viracta Therapeutics|VIRX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku viracta.com|VIRX - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Viracta Therapeutics|VIRX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Viracta Therapeutics, Inc.|VIRX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Viracta Therapeutics Inc.|VIRX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Viracta Therapeutics|Rasio jangkoan perantara viracta.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
VIRX - Bathi resik|Proyeksi bathi mangsa ngarep Viracta Therapeutics|VIRX - Pangali P/E|Prakiraan rega marang bathi Viracta Therapeutics, Inc.|VIRX - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Viracta Therapeutics Inc.|VIRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Viracta Therapeutics|VIRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan viracta.com|VIRX - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Viracta Therapeutics
- rincian pendapatan lan dodolan emiten:
VIRX - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Viracta Therapeutics|VIRX - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Viracta|VIRX - Wutah dodolan YoY sajrone rolas wulan kepungkur
Analisis umum perusahaan:Viracta Therapeutics, Inc.
Barang unggulan Viracta Therapeutics, Inc.

Viracta Therapeutics (VIRX) competes in the targeted lymphoma drug development segment. The P/E ratio measures the market value of a single unit of profit, determining the investment payback period through discounted cash flows. Investors weigh current research expenditures against potential revenue. Expectations for clinical trial results directly impact the company's P/E ratio. The dynamics of this metric reflect the market's valuation of the issuer's future success.

Pesaing wigati

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme Inc.)|RVMD (RevMed) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (ascentage.com)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis Corp (PSNL) - Rasio rega marang bathi|Erasca Corp - Nilai perusahaan marang bathi resik|DCTH (Delcath Systems Inc) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Therapeutics, Inc. YMAB|Pangali P/E AURA|Koefisien rega marang bathi Candel Therapeutics, Inc. CADL|Pangali P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rasio rega marang bathi|ACTU: Koefisien rega marang bathi|Citius Oncology, Inc. - Rasio rega pasar marang bathi resik|HURA (TuHURA Biosciences) - Koefisien rega marang bathi|TARA: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi FATE|WHWK: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TCRX (TScan Therapeutics Inc)|Periode bali modal bisnis Champions Oncology Inc|Pangali P/E XBIT (XBiotech Inc.)|Nilai perusahaan marang bathi resik CVM|OS Therapies Inc. - Pangali P/E|RADX - Pangali P/E|ARTV: Pangali P/E|ANL: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi VERU|TPST: Nilai perusahaan marang bathi resik|Rasio rega marang bathi xiliotx.com (XLO)|Renovaro - Pangali rega marang bathi|Rasio rega marang bathi Mural Oncology MURA|KAPA - Koefisien rega marang bathi|OKUR - Rasio rega marang bathi|GDTC - Pangali P/E|Curis, Inc. (CRIS) - Rasio rega marang bathi|Koefisien rega marang bathi Apollomics, Inc.|Koefisien rega marang bathi THAR|Pangali rega marang bathi ADVB (Advanced Biomed)|Koefisien rega marang bathi GNPX (Genprex, Inc)|CLDI: Kapitalisasi marang bathi resik|Rasio rega marang bathi sunshinebiopharma.com SBFM|XBIO - Koefisien rega marang bathi|SLRX: Koefisien rega marang bathi|Purple Biotech - Rasio rega pasar marang bathi resik|American Oncology Network (AONC) - Rasio rega marang bathi|Pangali rega marang bathi BGNE|Koefisien rega marang bathi CKPT|Rasio rega marang bathi ELEV|Pangali P/E ICAD|Pangali P/E Ikena Oncology Inc. (IKNA)|Pangali P/E NTBL (Notable Labs Ltd)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV